Regional variability in human immunodeficiency virus (HIV) care engagement remains underexplored. Multiple logistic models compared HIV outcomes for participants from 5 Southern (n = 557) and 6 non-Southern (n = 670) sites. Southern participants were less likely to experience viral suppression (adjusted odds ratio [aOR], 0.52; 95% confidence interval [CI], .37-.72) and had a higher likelihood of a CD4 + count <200 cells/µL (aOR, 1.53; 95% CI, 1.17-2.00). HIV intervention and social safety net programs should be expanded.
Improving care engagement and viral suppression among human immunodeficiency virus (HIV)-infected individuals is vitally important to reducing morbidity, mortality, and HIV transmission [1] . Certain populations, including racial/ethnic minorities, males, and adolescents, face extensive barriers to HIV care engagement and viral suppression [2, 3] . Substance use is also a major contributor to negative HIV-related outcomes [4] .
Few studies have examined regional differences in access to HIV-related care and outcomes. The Centers for Disease Control and Prevention (CDC) has identified the South as the new epicenter of the HIV epidemic in the United States [5] . Data suggest that Southern states tend to have lower rates of care linkage and engagement than those in the North and Midwest [6, 7] , and higher HIV-related mortality and poorer survival [8] . Identifying geographic differences in treatment and care outcomes could assist policy makers in tailoring interventions, updating policies, and determining areas of greatest need.
This secondary analysis used screening data from a randomized controlled trial to examine differences in antiretroviral (ART) history, care retention, HIV outcomes, and substance use treatment participation among hospitalized HIV-infected patients across 5 Southern compared with 6 non-Southern US sites.
METHODS
The study analyzed screening data from the National Institute on Drug Abuse Clinical Trials Network 0049 study (NCT01612169). From July 2012 to January 2014, 2291 HIV-infected patients were screened for participation in Hospital visit as an Opportunity for Prevention and Engagement for HIV Infected Drug Users (Project HOPE) [9] , which assessed whether a patient navigation intervention (with or without contingency management) impacted HIV viral suppression. While all sites began by screening all HIV-infected patients in the hospital whom medical staff had cleared for approach, a few Project HOPE sites initiated prescreening at a later stage; this analysis includes participants recruited before the prescreening process (N = 1227).
Recruitment occurred in 11 hospitals across the United States that had a high (>200 unique patients per year) HIV inpatient census and high prevalence of substance use among HIV-infected patients; the majority of patients were admitted for HIV-, substance use-, or psychiatric-related reasons. The geographic classification of sites in the study as Southern vs non-Southern was based on the CDC definition [5] ; there was no difference in the percentage of people approached for screening between the Southern and non-Southern sites. Institutional review boards at all participating institutions approved this research, and patients provided written informed consent. Southern sites included Atlanta, Georgia; Baltimore, Maryland; Birmingham, Alabama; Dallas, Texas; and Miami, Florida. NonSouthern sites included Boston, Massachusetts; Chicago, Illinois; Los Angeles, California; New York, New York; and Philadelphia and Pittsburgh, Pennsylvania. Of the 6 non-Southern hospitals, 3 were private, 2 were county/state government, and 1 was both state and private; of the 5 Southern hospitals, 2 were private and 3 were county/state government.
Measures
Sociodemographics, substance use treatment, health status, and healthcare utilization data were collected using standard measures (for more details, see Metsch et al [9] ).
Statistical Analyses
To compare participants living in Southern vs non-Southern sites, we used Pearson χ 2 tests for categorical variables, a t test for age, and Wilcoxon signed-rank test for viral load and CD4 + counts. Participants in these analyses were nested within sites.
To account for the potential site effect at a participant level, we used generalized estimating equation models to evaluate the association between living in a Southern vs non-Southern site, problematic drug/alcohol use, HIV care engagement, antiretroviral adherence, CD4 + count, and viral load while controlling for sociodemographic variables including age, gender, race, employment, relationship status, housing, health insurance, food security, and substance use. We report adjusted odds ratios (aORs) with 95% confidence intervals (CIs). Analyses were performed using SAS statistical software version 9.3 (SAS Institute, Cary, North Carolina). All tests were performed at a significance level of .05.
RESULTS
A total of 1227 participants were screened and included in these analyses: 557 in Southern sites and 670 in non-Southern sites. Just over two-thirds of the sample was male; 12% self-identified as Hispanic, 66% black, 16% white, and 6% as other racial/ethnic group. The median age was 48 years. Nearly two-thirds had a high school education or greater and had never married. Most had an annual income of $20 000 or less (86%) and reported stable housing (72%) and health insurance (80%). Nearly twothirds reported a lifetime history of incarceration and one-quarter reported insufficient food in the past month. Just over half reported having ever used drugs and, among those, nearly half had attended substance use treatment in their lifetime and 40% in the last year. Eighty-eight percent reported having ever been in HIV care and, among participants with a primary HIV provider, 90% had a past-year visit. The majority (80%) reported currently taking ART. Approximately half had a CD4 + count <200 cells/µL (49%) while 43% were virally suppressed. There were significant sociodemographic differences between participants in Southern vs non-Southern sites. Participants in Southern sites were more likely to be younger (45.8 vs 47.5 years; P < .01), black (70.9% vs 62.6%; P < .001), disabled (55.7% vs 43.8%; P < .001), and uninsured (23.6% vs 17.1%; P < .01). They were less likely to report a hepatitis C diagnosis (31.6% vs 37.9%; P = .023), be unemployed (22.9% vs 37.3%; P < .001), or to have been incarcerated in the last 6 months (6.7% vs 10.6%; 
DISCUSSION
This study among hospitalized HIV-infected participants across 11 sites in the United States found that while participants living in Southern sites had lower rates of problematic drug alcohol use, they were less likely to report care engagement and more likely to have worse HIV outcomes. Specifically, almost two-thirds of HIV-infected participants recruited from the Southern hospitals presented with a detectable viral load compared with half of participants in the non-Southern hospitals. While we cannot infer the reasons for this difference in viral suppression, the majority of participants were low-income ethnic/racial minorities who faced multiple health disparities including unstable housing, food insecurity, unemployment, disability, and educational level. These problems may be particularly acute in Southern sites, where social safety net programs to address these issues may be especially underfunded or unavailable [8, 10] . Also, research suggests that individuals in the South report higher levels of HIV-related stigma, homophobia, and racism than those in the North [5, 8] ; Southern states are also more likely to have anti-sodomy laws and abstinence-only education in schools [11] . These contextual factors have been shown to be associated with suboptimal healthcare engagement, medication adherence [12] , and awareness of HIV prevention measures such as preexposure prophylaxis [13] .
In addition to social-structural policy differences between the North and South, there are also regional variations between state and federal funding streams for HIV prevention and treatment that may have influenced study results. For instance, the amount the Ryan White Program provided per HIV-infected individual was, on average, $2912 in the Southern sites in this study and $3250 in the non-Southern sites; however, overhead and personnel costs are often lower in the South [14] . These discrepancies may be further exacerbated by the lack of Affordable Care Act-supported Medicaid expansion in most Southern states [15] . There were limitations to this study. This population represents a geographically diverse sample from 11 cities; however, this was a secondary analysis, so results are exploratory. While we controlled for many potential confounders, our findings may be influenced by unmeasured factors; as a cross-sectional analysis, causality cannot be inferred. Study sites were urban, further limiting the generalizability to areas such as the rural South. To enroll, participants had to be hospitalized at major medical centers and were therefore already accessing care, albeit emergency care. Variables related to risk factors and the use of HIV care, substance use disorders treatment, ART adherence, and kept medical appointments were based on self-report, but the screening process relied on medical records to document the presence or suppression of viremia. Participants represent a hospitalized population with more advanced HIV disease, limiting our ability to contribute generalizable data to the overall HIV continuum of care.
In conclusion, in this secondary analysis, HIV participants in the Southern sites were less likely to be engaged in care and to be virally suppressed compared with participants from non-Southern sites. These findings are consistent with other research that has shown HIV resources, Medicaid, and social safety-net programs that may benefit populations at high risk for HIV are generally underfunded in the South compared with other parts of the United States.
